Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

Presentation CIT 2019

DESSOLVE C: A Randomized Multi-Center Controlled Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

Presenter: Bin Wang, Yaling Han

March 28, 2019

Presentation CIT 2019

HBR studies and cases examples of HBR patients

Presenter: MC Morice

March 28, 2019

Presentation CIT 2019

Treatment of Left Main Bifurcation Lesion Using Two-Stent Strategy

Presenter: Jean Fajadet

March 28, 2019

Presentation CIT 2019

Could Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery Increase the Risk of Death?

Presenter: Sahil A. Parikh

March 28, 2019

Presentation CIT 2019

Bifurcation Treatment 2019

Presenter: Evald H. Christiansen

March 28, 2019

Presentation CIT 2019

Updates on Global Collaboration in Medical Device Research 2019

Presenter: Mitchell W. Krucoff

March 28, 2019

Presentation CIT 2018

Provisional Stenting For Bifurcatin Lesions

Presenter: Jean Fajadet

March 23, 2018

Presentation CIT 2014

Clinical outcomes of paclitaxel coated balloon angioplasty in an unselected patient population with drug eluting stent in-stent restenosis: Results from the French GARO Registry

Presenter: M Bedossa

March 22, 2014

Presentation CIT 2014

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

Presenter: Gao Runlin

March 22, 2014

Presentation CIT 2014

RESOLUTE China Registry: 1 Year (N = 1800) and 2 Year (N = 830) Outcomes from an All-Comers Chinese Population of Patients Implanted with the Resolute™ Zotarolimus-Eluting Stent

Presenter: Dr. Chen Shaoliang

March 22, 2014

Presentation CIT 2014

First Report of DAPT and CoCr Everolimus-Eluting Stent in Chinese Population: Two-Year Results from the Prospective Multicenter SEEDS Study-An Investigator Sponsored Study (ISS)

Presenter: Yelin Zhao

March 22, 2014

Presentation CIT 2014

CREDIT I: A First-In-Man Study of the Second Generation EXCEL Biodegradable PolymerSirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT Results

Presenter: Han Yaling

March 22, 2014

Presentation CIT 2014

A Prospective, Multicenter, Randomized Trial of YINYI Polymer-Free Paclitaxel-Eluting Stent vs. Durable Polymer Sirolimus-Eluting Stent in the Treatment of Coronary Artery Disease

Presenter: Yong Huo

March 22, 2014

Presentation CIT 2014

Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stents at 3 months follow-up: The BuMA-OCT Randomized Trial

Presenter: Yao-Jun Zhang

March 22, 2014

Presentation CIT 2014

AIR-CTO TrialComparison of Angiography- versus IVUS- guided Stent Implantation for Chronic Total Coronary Occlusion Recanalization

Presenter: Shao-Liang Chen

March 21, 2014

Presentation CIT 2014

DES Innovation from China - Target Eluting Stent

Presenter: Qiyi Luo

March 20, 2014

Presentation CIT 2013

Coronary In-stent Restenosis: A Settled Clinical Indication in the DES World ?

Presenter: Kenneth Chin

March 22, 2013

Advertisement

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

DESSOLVE C: A Randomized Multi-Center Controlled Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

HBR studies and cases examples of HBR patients

Treatment of Left Main Bifurcation Lesion Using Two-Stent Strategy

Could Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery Increase the Risk of Death?

Bifurcation Treatment 2019

Updates on Global Collaboration in Medical Device Research 2019

Provisional Stenting For Bifurcatin Lesions

Clinical outcomes of paclitaxel coated balloon angioplasty in an unselected patient population with drug eluting stent in-stent restenosis: Results from the French GARO Registry

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

RESOLUTE China Registry: 1 Year (N = 1800) and 2 Year (N = 830) Outcomes from an All-Comers Chinese Population of Patients Implanted with the Resolute™ Zotarolimus-Eluting Stent

First Report of DAPT and CoCr Everolimus-Eluting Stent in Chinese Population: Two-Year Results from the Prospective Multicenter SEEDS Study-An Investigator Sponsored Study (ISS)

CREDIT I: A First-In-Man Study of the Second Generation EXCEL Biodegradable PolymerSirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT Results

A Prospective, Multicenter, Randomized Trial of YINYI Polymer-Free Paclitaxel-Eluting Stent vs. Durable Polymer Sirolimus-Eluting Stent in the Treatment of Coronary Artery Disease

Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stents at 3 months follow-up: The BuMA-OCT Randomized Trial

AIR-CTO TrialComparison of Angiography- versus IVUS- guided Stent Implantation for Chronic Total Coronary Occlusion Recanalization

DES Innovation from China - Target Eluting Stent

Coronary In-stent Restenosis: A Settled Clinical Indication in the DES World ?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content